David Schwab
Founder & Managing Director @ Vertical Venture Partners
San Francisco, United States
David Schwab is a Series B investor at Vertical Venture Partners in San Francisco focused on Software and Enterprise Software. David Schwab is the Founder and Managing Director at Vertical Venture Partners. Dave joined Sierra in 1996. Prior to joining the venture capital community, Dave's professional career began at Lockheed Corporation in the software engineering department. Following his tenure there, he joined Sun Microsystems in sales and sales management. In1991 Schwab co-founded Scopus Technology with a fellow Sun sales manager and two other executives. While at Scopus, he served as Vice President of Sales and Marketing. Scopus was taken public and subsequently acquired by Siebel Systems.Dave holds a Masters in aerospace engineering from Stanford University and an MBA from Harvard University.Lockheed Corporation, 1979-1984, Engineering , Sun Microsystems, 1986-1991, Sales Management , Scopus Technology, Inc., 1991-1996, Co-founder & Vice President of Sales , Sierra Ventures, 1996-PresentDirectorships of Public and Acquired Companies : 360Commerce, Inc. (Acquired by Oracle) , CrossLogix (Acquired by BEA Systems, Inc.) , Interact Commerce Corp. (IACT-NASD) , Knova (Merger of Kanisa and Service Ware) , Micromuse (MUSE-NASD) , Motiva (Acquired by Siebel Systems) , Onlink Technologies (Acquired by Siebel Systems)Directorships of Private Companies : Accruent , ClearApp (formerly Acsera) , Corrigo , CSS SlashSupport , DBS Communications , Infoton , Opalis , SeeCommerce,Vykor,ZillionTV, Zoom Systems
- Total investments:
- 24
- Last investment:
- Lead investor:
- 54%
Last updated:
For AI agents: llms.txt
Industries David Schwab invests in
Stages David Schwab invests in
Countries David Schwab invests in
Investment Focus
Industry
- Software 5 (21%)
- Enterprise Software 5 (21%)
- SaaS 3 (13%)
- Artificial Intelligence 3 (13%)
- Health Care 2 (8%)
Stage
- Series B 4 (17%)
- Seed 3 (13%)
- Series A 3 (13%)
- Series C 2 (8%)
- Series D 2 (8%)
Country
- United States 10 (42%)
- United Kingdom 1 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Mongoose Software
|
Mongoose Software unlocks the next era of healthcare innovation, and it gives product and experience teams the freedom to create without engineering bottlenecks. | Seed / May 13, 2026 | |
|
Mongoose Software
|
Mongoose Software unlocks the next era of healthcare innovation, and it gives product and experience teams the freedom to create without engineering bottlenecks. | Seed / Sep 17, 2025 | |
Scout
|
Scout aims to help growers, wineries, and vineyard management companies achieve financial objectives, grow better fruit, and increase yields using data from the growing season. It is an AI-powered farm management data platform that aids vineyard managers in making data-driven decisions, promoting proactive farming, efficiency, and climateresilience, while also providing historical records. | $3M / Seed / Apr 09, 2024 | |
OnsiteIQ
|
OnsiteIQ is a construction intelligence platform purpose-built for real estate owners and investors. We capture 100% of every asset in a portfolio on a recurring basis during construction and provide insights to help monitor progress and verify payments. It brings every site directly to the development manager into a simple dashboard accessiblefrom anywhere to help reduce delays and optimize returns. | $14M / Series B / Oct 24, 2023 | |
WhizAI
|
WhizAI is the first and only AI-powered analytics platform purpose-built for life sciences and healthcare. It puts insights directly into the hands of business users empowering decision-makers to drive more informed and faster business decisions at lower cost. With its deep understanding of the life sciences and healthcare domains and user intent,the platform delivers insights without the delays of traditional BI dashboards. Fast, easy, and scalable, WhizAI is transforming analytics with artificial intelligence optimized for life sciences and healthcare making WhizAI the trusted partner of choice at top global companies.Simply ask a question about sales, market access, patient services, or clinical trials -- and WhizAI answers it instantly. WhizAI's conversational interface allows users to simply talk to the enterprise data giving them complete autonomy to drill into every level of detail along with real-time updates. WhizAI’s advanced machine learning algorithms scan entire data sets to deliver proactive alerts and automatically surface anomalies, easily pinpointing stagnating sales, market share changes, patient drop-offs and much more.WhizAI enjoys nearly 100% adoption by business users, contributes to a 60% reduction in calls to IT and a 50% reduction in operational overhead within the first few months of implementation. | $6M / Series A / Oct 25, 2022 | |
Concert Health
|
Concert Health focuses on building an integrated behavioral health system. The company starts by helping medical groups integrate behavioral health services into their practices. It specializes in the fields of information technology, medical, and health care. It was founded in 2016 and headquartered in San Diego, California. | $42M / Series B / Apr 27, 2022 | |
ONI
|
ONI is a pioneer of super-resolution microscopy, making this advanced technology accessible to new generations of researchers. The Nanoimager, the world's first benchtop sized super-resolution microscope, delivers a step change in usability and precision. This, together with our next-generation consumable products will empower academicresearchers, clinicians and scientists to on a path to discovery.The microscope offers easy access to a range of super-resolution techniques including dSTORM and PALM, as well as smFRET, single-particle tracking and confocal.The company's achievements have been recognised by FastTrack100 who named ONI on their 2018 list of 10 Disruptors to Watch and ONI won Best Business Start-up at the 2018 IOP Awards. More and more life science researchers and pharma companies are taking an interest in ONI and it now has customers using its products in leading laboratories across the globe, including the Universities of Oxford, Cambridge and Harvard.ONI has a restless enthusiasm to make the world a better place. Our ambition is to bring super-resolution fluorescence imaging to a new community of researchers and we are removing barriers to make science more effective, accessible and affordable. Our vision is to accelerate scientific discovery and fight disease by enabling everyone to visualize, understand and share the microscopic details of life. | $75M / Series B / Dec 24, 2021 | |
|
WhizAI
|
WhizAI is the first and only AI-powered analytics platform purpose-built for life sciences and healthcare. It puts insights directly into the hands of business users empowering decision-makers to drive more informed and faster business decisions at lower cost. With its deep understanding of the life sciences and healthcare domains and user intent,the platform delivers insights without the delays of traditional BI dashboards. Fast, easy, and scalable, WhizAI is transforming analytics with artificial intelligence optimized for life sciences and healthcare making WhizAI the trusted partner of choice at top global companies.Simply ask a question about sales, market access, patient services, or clinical trials -- and WhizAI answers it instantly. WhizAI's conversational interface allows users to simply talk to the enterprise data giving them complete autonomy to drill into every level of detail along with real-time updates. WhizAI’s advanced machine learning algorithms scan entire data sets to deliver proactive alerts and automatically surface anomalies, easily pinpointing stagnating sales, market share changes, patient drop-offs and much more.WhizAI enjoys nearly 100% adoption by business users, contributes to a 60% reduction in calls to IT and a 50% reduction in operational overhead within the first few months of implementation. | $8M / Series A / Dec 14, 2021 | |
|
Concert Health
|
Concert Health focuses on building an integrated behavioral health system. The company starts by helping medical groups integrate behavioral health services into their practices. It specializes in the fields of information technology, medical, and health care. It was founded in 2016 and headquartered in San Diego, California. | $14M / Series A / Jan 28, 2021 | |
PowWow Mobile
|
PowWow Mobile is redefining the mobile enterprise. Their rapid mobile app solution, SmartUX, enables organizations to simplify and extend business apps to mobile by modernizing and streamlining existing processes to deliver new and intelligent enterprise to edge experiences. The company's SmartUX Platform simplifies and extends business appsto mobile, delivering modern omnichannel experiences that empower an anytime, anywhere workforce.The SmartUX enables organizations to simplify and extend business apps to mobile by modernizing and streamlining existing processes to deliver new and intelligent “enterprise to edge” experiences. It also provides a low-code, drag, and drops environment for rapidly creating and deploying secure cross-platform mobile apps. With unmatched accessibility and ease-of-use, our solution facilitates collaboration between IT and the business, significantly reducing backlogs and accelerating time to value.Based in San Francisco, PowWow Mobile has garnered prestigious awards and recognition from AOTMP, Compass Intelligence, Gartner and more. | $4.3M / Seed / May 04, 2016 | |
| See all 24 investments → | |||
Co-Investors
About Vertical Venture Partners
Vertical Venture Partners ("VVP") is a venture capital firm investing in enterprise technology companies that target specific vertical markets. VVP focuses on companies with solutions for pain points that are C-suite priorities. Some vertical markets of interest include: Aerospace and Defense, Energy, Financial Services, Healthcare,Insurance, Real Estate, Retail, and Transportation. Some technology areas of interest include: Business Intelligence, Cloud Applications, CRM, Mobile, Security, Software Infrastructure, Instrumentation and Materials Science.
Vertical Venture Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Brad Corona
Managing Director
|
|||
|
David Schwab
Founder & Managing Director
|
|||
|
Matthew Schwab
Associate
|
|||
Paul Conley
Managing Director
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does David Schwab invest in?
David Schwab invests primarily in Software, Enterprise Software and SaaS startups, most often at Series B and Seed stage. Most of the 24 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did David Schwab last invest?
The most recent investment recorded for David Schwab closed in May 2026. Shizune tracks 24 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
